Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole Infusion vs Second Endoscopy for Peptic Ulcer Rebleeding
NCT00164931Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of omeprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Recurrent bleeding within 30 days after initial endoscopy. Started Oct 2003; status: completed.
02
Drugs
omeprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT00164931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164931.